Cargando…
Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension
OBJECTIVE: The efficacy and safety of 1‐month atomoxetine and midodrine therapies were compared. Three‐month atomoxetine and combination therapies were investigated for additional benefits. METHODS: This prospective open‐label randomized trial included 50 patients with symptomatic neurogenic orthost...
Autores principales: | Byun, Jung‐Ick, Kim, Do‐Yong, Moon, Jangsup, Shin, Hye-Rim, Sunwoo, Jun‐Sang, Lee, Woo‐Jin, Lee, Han‐Sang, Park, Kyung‐Il, Lee, Soon‐Tae, Jung, Keun‐Hwa, Jung, Ki‐Young, Kim, Manho, Lee, Sang Kun, Chu, Kon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952305/ https://www.ncbi.nlm.nih.gov/pubmed/31856425 http://dx.doi.org/10.1002/acn3.50968 |
Ejemplares similares
-
Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension
Publicado: (2020) -
Association of blood pressure variability with orthostatic intolerance symptoms
por: Sunwoo, Jun-Sang, et al.
Publicado: (2017) -
Midodrine for orthostatic hypotension
Publicado: (2020) -
Orthostatic intolerance symptoms are associated with depression and diminished quality of life in patients with postural tachycardia syndrome
por: Moon, Jangsup, et al.
Publicado: (2016) -
Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease
por: Kremens, Daniel, et al.
Publicado: (2017)